Slides and Webcasts from all ESMO Advanced Courses are reserved to ESMO Members and registered participants, according to the presenters' agreement to release them. ESMO thanks the authors for their generosity.
ESMO Advanced Course on Deep Dive in CDK4-6 Inhibitors Data in Breast Cancer 2023: Dubai
- Start date
- 20 May 2023
- End date
- 20 May 2023
- Location
- Dubai, United Arab Emirates
Learning objectives
- Understanding the function and biology of CDK4-6 in malignant breast cancer cells
- Information and in-depth discussion on the state of the art and emerging therapeutic strategies integrating CDK4-6 inhibition in breast cancer, both in the metastatic setting
- Presenting novel data on biomarkers of benefit, mechanisms of resistance and combinatorial therapeutic strategies of CDK4-6 inhibition
- Providing an outlook of potential integration of CDK 4-6 inhibitors in the adjuvant setting
- Discussing clinical cancer cases to integrate use of CDK 4-6 inhibitors in clinical practice
Accreditation
The programme of this event has been accredited with 6 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary skills and standards for the practice of medical oncology. For further details, please refer to ESMO-MORA Recertification Process & Requirements.
Co-Chairs
- Giuseppe Curigliano, Italy
- Barbara Pistilli, France
Supported by
